Free Trial

Accuray (ARAY) Competitors

Accuray logo
$2.32 +0.10 (+4.50%)
Closing price 01/30/2025 04:00 PM Eastern
Extended Trading
$2.33 +0.01 (+0.22%)
As of 04:20 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ARAY vs. OFIX, SRDX, ANGO, RMTI, RSLS, ABT, ISRG, SYK, BSX, and MDT

Should you be buying Accuray stock or one of its competitors? The main competitors of Accuray include Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Boston Scientific (BSX), and Medtronic (MDT). These companies are all part of the "health care equipment" industry.

Accuray vs.

Accuray (NASDAQ:ARAY) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, community ranking, risk, institutional ownership, earnings, dividends and analyst recommendations.

Accuray has higher earnings, but lower revenue than Orthofix Medical. Accuray is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Accuray$446.55M0.52-$15.55M-$0.17-13.65
Orthofix Medical$784.25M0.91-$151.40M-$3.13-5.96

Orthofix Medical received 82 more outperform votes than Accuray when rated by MarketBeat users. However, 65.61% of users gave Accuray an outperform vote while only 61.98% of users gave Orthofix Medical an outperform vote.

CompanyUnderperformOutperform
AccurayOutperform Votes
332
65.61%
Underperform Votes
174
34.39%
Orthofix MedicalOutperform Votes
414
61.98%
Underperform Votes
254
38.02%

Accuray has a net margin of -3.72% compared to Orthofix Medical's net margin of -15.18%. Orthofix Medical's return on equity of -21.25% beat Accuray's return on equity.

Company Net Margins Return on Equity Return on Assets
Accuray-3.72% -36.93% -3.52%
Orthofix Medical -15.18%-21.25%-13.29%

In the previous week, Orthofix Medical had 3 more articles in the media than Accuray. MarketBeat recorded 6 mentions for Orthofix Medical and 3 mentions for Accuray. Orthofix Medical's average media sentiment score of 0.92 beat Accuray's score of 0.38 indicating that Orthofix Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Accuray
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Orthofix Medical
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Accuray presently has a consensus target price of $9.00, indicating a potential upside of 287.93%. Orthofix Medical has a consensus target price of $23.33, indicating a potential upside of 25.11%. Given Accuray's stronger consensus rating and higher possible upside, analysts clearly believe Accuray is more favorable than Orthofix Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Accuray
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Orthofix Medical
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

Accuray has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 1.1, suggesting that its share price is 10% more volatile than the S&P 500.

64.1% of Accuray shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 4.2% of Accuray shares are owned by company insiders. Comparatively, 2.6% of Orthofix Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Accuray and Orthofix Medical tied by winning 9 of the 18 factors compared between the two stocks.

Get Accuray News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARAY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ARAY vs. The Competition

MetricAccuraySurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$233.32M$4.88B$5.61B$9.14B
Dividend YieldN/A52.56%5.36%3.98%
P/E Ratio-13.6526.4289.6917.66
Price / Sales0.5253.761,219.4081.09
Price / CashN/A52.0644.3437.71
Price / Book5.168.245.134.73
Net Income-$15.55M$13.79M$118.85M$225.42M
7 Day Performance1.31%0.19%1.87%-0.44%
1 Month Performance29.61%9.80%7.96%3.57%
1 Year Performance-14.07%45.36%26.70%19.20%

Accuray Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ARAY
Accuray
4.4714 of 5 stars
$2.32
+4.5%
$9.00
+287.9%
-14.1%$233.32M$446.55M-13.651,040Upcoming Earnings
Short Interest ↑
OFIX
Orthofix Medical
3.7255 of 5 stars
$18.34
-0.1%
$23.33
+27.3%
+31.9%$700.58M$746.64M-5.861,634Analyst Upgrade
Short Interest ↓
SRDX
Surmodics
4.3688 of 5 stars
$37.90
-0.7%
$50.00
+31.9%
+1.5%$541.52M$126.08M-46.78450Earnings Report
Upcoming Earnings
Analyst Forecast
Short Interest ↑
Analyst Revision
News Coverage
ANGO
AngioDynamics
4.0157 of 5 stars
$12.18
-0.1%
$13.00
+6.7%
+108.7%$492.88M$303.91M-2.16760Short Interest ↓
RMTI
Rockwell Medical
4.3669 of 5 stars
$2.06
-6.6%
$6.00
+192.0%
+45.8%$66.42M$83.61M-41.10300Gap Down
RSLS
ReShape Lifesciences
0.9554 of 5 stars
$4.36
-1.9%
N/A-69.5%$3.18M$8.68M0.0050Short Interest ↓
ABT
Abbott Laboratories
4.9056 of 5 stars
$129.38
+3.5%
$133.06
+2.8%
+13.5%$223.73B$41.95B16.86114,000Short Interest ↑
ISRG
Intuitive Surgical
4.703 of 5 stars
$573.67
-1.8%
$613.10
+6.9%
+53.8%$204.33B$7.12B92.2313,676Insider Trade
Short Interest ↑
SYK
Stryker
4.8912 of 5 stars
$398.27
+1.0%
$405.80
+1.9%
+23.2%$151.29B$20.50B42.5452,000Earnings Report
Analyst Forecast
Analyst Revision
Positive News
BSX
Boston Scientific
4.766 of 5 stars
$102.04
+0.1%
$97.26
-4.7%
+67.6%$150.41B$14.24B84.3448,000Upcoming Earnings
Analyst Upgrade
Short Interest ↑
Positive News
MDT
Medtronic
4.8535 of 5 stars
$92.20
+2.2%
$95.00
+3.0%
+5.8%$118.03B$32.36B28.1595,000Short Interest ↓
Positive News

Related Companies and Tools


This page (NASDAQ:ARAY) was last updated on 1/31/2025 by MarketBeat.com Staff
From Our Partners